"Injection Site Reaction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Adverse reactions that occur initially at the site of injection or infusion. Milder type is confined to a local allergic flare reaction. A more severe reaction is caused by extravasation of VESICANTS from the blood vessel at the site of injection and can cause damage to the surrounding tissue. In tumor flare reaction symptoms involve well beyond the injection site such as an increase in the tumor size and tumor markers levels, bone pain, and HYPERCALCEMIA.
| Descriptor ID |
D000075662
|
| MeSH Number(s) |
C23.550.340.500 C25.100.781
|
| Concept/Terms |
Injection Site Reaction- Injection Site Reaction
- Injection Site Reactions
- Injection Site Event
- Injection Site Events
- Injection Site Adverse Event
Infusion Site Reaction- Infusion Site Reaction
- Infusion Site Reactions
- Infusion Site Adverse Reaction
- Infusion Site Adverse Event
|
Below are MeSH descriptors whose meaning is more general than "Injection Site Reaction".
Below are MeSH descriptors whose meaning is more specific than "Injection Site Reaction".
This graph shows the total number of publications written about "Injection Site Reaction" by people in this website by year, and whether "Injection Site Reaction" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 2 | 3 |
| 2019 | 2 | 2 | 4 |
| 2021 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Injection Site Reaction" by people in Profiles.
-
Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: a 6-month retrospective study. Clin Exp Dermatol. 2022 Jan; 47(1):157-158.
-
Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12-15 years. Arch Dis Child. 2022 02; 107(2):205-207.
-
Safety of COVID-19 vaccines. J Med Virol. 2021 Dec; 93(12):6588-6594.
-
COVID-19 Vaccine Reactions in Dermatology: "Filling" in the Gaps. Cutis. 2021 06; 107(6):288-290.
-
Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series. JAMA Dermatol. 2021 06 01; 157(6):716-720.
-
Recurrent injection-site reactions after incorrect subcutaneous administration of a COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2021 09; 35(9):e545-e546.
-
Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. J Med Virol. 2021 Jul; 93(7):4420-4429.
-
"COVID Arm": Very delayed large injection site reactions to mRNA COVID-19 vaccines. J Allergy Clin Immunol Pract. 2021 06; 9(6):2480-2481.
-
Coronavirus Vaccination Adverse Reactions and the Role of the Dermatologist. J Drugs Dermatol. 2021 03 01; 20(3):351-352.
-
Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial. Trials. 2021 Feb 25; 22(1):162.